Author: [AUTHOR] Published on 3/1/2020 12:00:00 AM
Daniela J. Conrado, PhD, Belmont, MA
Dr. Conrado became of member of ASCPT in 2011. She was referred by her colleague Daniel Gonzalez. She believes that ASCPT offers a great deal of opportunities. In 2012, she felt honored to be recognized as an ASCPT Presidential Trainee. As she has grown in her career, her benefit from ASCPT has matured. She explains that she enjoys “the ASCPT webinars, as a continued education mechanism during all year round.” She also appreciates the value she draws from the Annual Meeting in terms of networking and discussing emerging topics. At the most recent Annual Meeting in Washington, DC, she co‐chaired a symposium with her fellow member Mohamed Shahin and received a “Top Poster” designation on her abstract: “Toward FDA and EMA Endorsement of Clinical Trial Simulation Tolls to Increase Efficacy of Drug Development in Mild Cognitive Impairment and Early Parkinson Disease.”
Dr. Conrado is working to develop quantitative solutions for unmet medical needs. The work that she does helps optimize the drug development process by increasing the likelihood of detecting beneficial or harmful drug effects in clinical trials.
Dr. Conrado serves as one of the Editors‐in‐Training for CPT: Pharmacometrics & Systems Pharmacology